11:10-12:00, Rm 103

More documents

Recommendations

Info

Protein: modification and regulationR-18-13Effect of lysine-containing cationic domains to thermal transition ofelastin-like proteins and their sensitivity to salt and pHWon Bae JeonLaboratory of Biochemistry and Cellular Engineering, Daegu Gyeongbuk Institute of Science andTechnology, Daegu 711-873, KoreaElastin-like proteins (ELPs) that are modeled on the VPGXG pentapeptide repeat oftropoelastin, in which X is any amino acid except proline, display a soluble-insolublephase transition in response to changes in temperature, salt, or pH, and thus haveemerged as promising smart proteins for biomedical applications. The temperature atwhich the soluble-insoluble conformational change occurs, known as the inversetransition temperature (Tt), has been used to characterize the responsiveness of ELPs toa change in stimulating factors. A series of elastin-like proteins, SKGPG[V(VKG)3VKVPG]n-(ELP1-90)WP (n = 1, 2, 3, and 4), were biosynthesized based on thehydrophobic and lysine linkage domains of tropoelastin. The formation of self-assembledhydrophobic aggregates was monitored in order to determine the influence of lysinecontainingcationic domains on phase transition properties as well as the sensitivity tochanges in salt and pH. The thermal transition profiles of the proteins fused with only oneor two cationic blocks (n = 1 or 2) were similar to that of the counterpart ELP1-90. Incontrast, diblock proteins that contain 3 and 4 cationic blocks displayed a triphasic profileand no transition, respectively. Upon increasing the salt concentration and pH, a stimulusinducedphase transition from a soluble conformation to an insoluble aggregate wasobserved. The effects of cationic segments on the stimuli sensitivity of cationic bimodalELPs were interpreted in terms of their structural and molecular characteristics.R-18-16Glutathione enhances the functional efficiency of a traffickingchaperone involved in intracellular B12 metabolismJinju Jeong, Yeonju Choi and Jihoe Kim*School of Biotechnology, Yeungnam University, KoreaThe most common inherited disorder of intracellular B12 metabolism belongs to cblCgenetic complementation group. The defective gene product CblC is a traffickingchaperone for escorted delivery of B12 in the cytoplasm. The protein binds andprocesses vitamin B12 in enzyme cofactor assimilation, but the binding affinity waspreviously reported to be relatively low (Kd in a micromolar range) considering submicromolarB12 concentrations in cells. Using a bovine homologue protein bCblC, wefound that the binding affinity for vitamin B12 is increased up to 95-fold (Kd = 0.34 ±0.06µM) in the presence of reduced glutathione (GSH), which is abundant (1 ~ 10 mM) incells. The increased binding affinity appeared to be due to stabilization of ligand-boundbCblC upon binding of GSH, preventing the release of the ligand. These resultsdemonstrate that bCblC is more efficient B12 trafficking chaperone in vivo than previouslyreported. In addition, these findings suggest that vitamin B12 together with glutathioneshould be considered for the treatment of patients with a CblC defect.R-18-14Potential role of sumoylation in the activation and nuclear translocationof STAT6Seol-Hee Kim, Tran Thi Minh Tam and Choong-Eun LeeLaboratory of Immunology, Department of Biological Science, Sungkyunkwan University, Suwon440-746, KoreaSTATs, signal transducers and activators of transcription, undergo various posttranslationalmodifications (PTM) including phosphorylation, acetylation, methylation, andsumoylation which may affect STAT activation process and cytokine response. Recentlywe have reported the antagonistic regulation by IL-4 and IFN-alpha signaling mediatedthrough cytosolic retention of novel phospho-STAT(pY-STAT6:pY-STAT2:p48) complex.To elucidate molecular basis of the cytosolic localization, we have investigated the role ofPTMs in the nuclear translocation of STATs. The perturbation of methylation oracetylation did not affect the translocation of phospho-STAT1 or phospho-STAT6 inducedby IFN-alpha and/or IL-4. Interestingly, however, our data suggest the role of sumoylationfor STAT6 translocation. The sumo-plot prediction program revealed potentialsumoylation motifs in STAT6 at K131, K307, K618 and K636. In addition, the overexpressionof sumo-GFP and STAT6 resulted in an extensive cytoplasmic co-retention ofsumo-STAT6 and pY-STAT6 analyzed by confocal microscopy and immunoblot. Theresults indicate an involvement of sumoylation in the pY-STAT6-containing complexformation and inhibition of its nuclear translocation as implicated in the PIAS/STAT1interaction.R-18-18Characerization of cross-linked immobilized acyl-CoA thioesterase1precursor from the Listeria innocus CLIP 11262 and amyloid fibrils asnano-scaffoldSeul-Gi Kim, Song-Yi Bae, Seung-Joon Kim and T. Doo-Hun Kim*Department of Molecular Science and Technology, Ajou University, Suwon 443-749, KoreaCross-linked enzyme aggregates (CLEAs) were appeared as interesting enzyme designfor immobilization. In this approach used the LI22, which an enzyme that Acyl-CoAthioesterase1 precursor from L. innocus CLIP 11262. Efficient cross-linking was observedwhen using 80%-saturation ammonium sulfate followed by cross-linking for 12h-14h with0.5%(v/v) glutaraldehyde. The residual stability of the CLEA with respect to paranitrophenylactate was evaluated. The CLEA product was much more resistant todenature, heat than the soluble enzyme. As compared to its soluble enzyme form, solubleenzyme retained 20% of its activity after 1 h of incubation at 80 C and 75% of LI22-CLEA’s activity still observed after 2h of incubation at 80℃. During 15day of storage at 4℃, the LI22-CLEA retained more than 85% of its initial activity. Bovine insulin amyloidfiber were made on several conditions at pH2.0. We report successful functionalization ofamyloid fibrils by conjugation to LI22 using glutaraldehyde. We are currently investigatingbiochemical and biophysical properties of LI22-CLEA using several biochemical andbiophysical approaches including scanning electron microscopy (SEM). And we expectseveral roles of functionalized bovine insulin fibrils as nano-scaffold.R-18-15Tissue-specific and age-dependent expression of protein argininemethyltransferases (PRMTs) in rat tissuesEunyoung Hong, Eunil Lee, Yongchul Lim, Minyoung Oh, Daeho Kwon¹Department of Preventive Medicine & Medical Research Center for Environmental Toxico-Genomics and Proteomics, Korea University, Seoul, Korea, ²Department of Public Health, Schoolof Medicine, Graduate School of Medicine, Korea University, Seoul, Korea, ³Cellular andDevelopmental Biology, Division of Brain Korea 21 Program for Biomedical Sciences, KoreaUniversity, College of Medicine, Seoul 136-705, Korea, ⁴Department of Microbiology College ofMedicine Kwandong University 522 Naegok-dong, Gangneung-si, Kwangwon-do 210-701, KoreaProtein arginine methyltransferases generate asymmetric and symmetric dimethylargininesby catalyzing the transfer of methyl groups to the arginines in proteins. Wepreviously observed the expression and activities of PRMTs were significantly reduced inreplicatively senescent fibroblasts compared with young fibroblasts. In the present study,we investigated the expression of four PRMT members (PRMT 1, 4, 5, 6), symmetric andasymmetric arginine dimethylated proteins in age-dependent rat tissues. When theexpression of PRMTs and the methylation of their substrates were examined, asignificant reduction was found between old and young rat tissues. Although differenceswas distributed by a tissue-specific manner, most PRMTs were significantly downregulatedin several aged rat tissues compared with young rat tissues. Furthermore,when enzyme activity was determined with tissue extract, PRMT’s activity from aged rattissues was reduced. It was not routinely correlated with the expressed PRMTs, however,the data indicated that not only was the expressed PRMTs decreased in aged rat tissues,but also the enzymatic activities were reduced. These results suggest that the tissuespecificexpression patterns of PRMTs and their activities might affect the process of rattissue aging.330 Korean Society for Biochemistry and Molecular BiologyR-18-19The expression levels of Mfn1 in oxidative stress induced mitochondrialhyper-fusion is controlled by mitochondrial E3 ligase, MARCH5Yong-Yea Park and Hyeseong ChoDepartment of Biochemistry, Ajou University School of Medicine, Graduate School of MolecularScience and Technology, Ajou University, Wonchon-dong, Yeongtong-gu, Suwon 443-721, KoreaA mitochondrial E3 ubiquitin ligase, MARCH5, regulates mitochondrial morphology bybinding and controlling mitochondrial dynamics proteins. We previously reported thatMARCH5 lacking cells showed mitochondrial elongation which promotes cellularsenescence through Drp1 and accumulation of Mfn1. In this study, we proposed that thestress-induced mitochondrial hyperfusion (SIMH) induced by elevation of Mfn1 can beresolved by MARCH5. In response to Antimycin A (AMA) treatment, a mitochondrialcomplex III inhibitor, cells displayed SIMH and elevation of Mfn1 level was accompanied.Depletion of Mfn1 levels abrogates SIMH, indicating that Mfn1 plays an important role inSIMH. Notably, in AMA-treated cells, the interaction between MARCH5 and Mfn1 wasgreatly enhanced and ubiquitylation of accumulated Mfn1 was accelerated. Thus, inSIMH abnormally elevated Mfn1 levels in cells may trigger the activation of MARCH5,which returns the Mfn1 level to the basal. Together, we propose a novel mechanism thatthe balance of Mfn1 partly mediated through MARCH5 is important in maintaining of cellintegrity against cellular stress.
2011KSBMBAnnual MeetingStepping into the Future of BiomedicinePoster SessionS-18-01 ~ S-18-12Proteomics
Page 2 and 3:
SecretariatKorean Society for Bioch
Page 4 and 5:
345710111359616498160354404Invitati
Page 6 and 7:
General InformationRegistrationRegi
Page 8 and 9:
Science ManagerMin-Seon KimAsan Med
Page 10 and 11:
Tuesday, May 17, 2011Time8:00-9:00G
Page 12 and 13:
Hall InformationSeminar | Grand Bal
Page 14 and 15:
The poster board surface area is 95
Page 16 and 17:
Nobel Laureate LectureMay 17 (Tue),
Page 18 and 19:
KMA Plenary LectureMay 16 (Mon), 15
Page 20 and 21:
Moosa Plenary LectureMay 17 (Tue),
Page 22 and 23:
Donghun Award LectureSang-Hun LeeDe
Page 24 and 25:
Chungsan Award LectureSue Goo RheeD
Page 26 and 27:
Macrogen Woman Scientist Award Lect
Page 28 and 29:
Achievement Award of Paper - BMB re
Page 30 and 31:
Most Citation Paper Award - BMB rep
Page 32 and 33:
Most Number of Paper Award - BMB re
Page 34 and 35:
Merck Young Scientist Award Lecture
Page 36 and 37:
SymposiaS1Stem Cells and Cancer Ste
Page 38 and 39:
S3Aging and Mitochondria May 16 (Mo
Page 40 and 41:
S5Cell Cycle and Genetic Stability
Page 42 and 43:
S7Reactive Oxygen Species and Cell
Page 44 and 45:
S9Stem Cell and Differentiation-KNI
Page 46 and 47:
S11G-protein Coupled Receptors and
Page 48 and 49:
S13Development and Model Organisms
Page 50 and 51:
S15Innate Immunity and Host-Microbe
Page 52 and 53:
S17Neurodevelopment and Regeneratio
Page 54 and 55:
S19Cardiovascular Disease May 18 (W
Page 56 and 57:
Biomedical Lecture SeriesBLS1Autoph
Page 58 and 59:
BLS3Angiogenesis and Vascular Disea
Page 60 and 61:
BLS5Inflammation and Immunity May 1
Page 62 and 63:
Bio-Medical Science Co., LtdMay 17
Page 65 and 66:
2011KSBMBAnnual MeetingStepping int
Page 67:
KMA Plenary LectureNuclear receptor
Page 70 and 71:
Donghun AwardStem cell biology for
Page 72 and 73:
Stem Cells and Cancer Stem Cells, C
Page 74 and 75:
The Early Stage of Plant Developmen
Page 76 and 77:
Reactive Oxygen Species and Cell Si
Page 78 and 79:
Stem Cell and Differentiation-KNIH
Page 80 and 81:
TGF-βSignaling and Its Therapeutic
Page 82 and 83:
Post-Transcriptional Regulation and
Page 84 and 85:
Neurodevelopment and RegenerationS1
Page 86 and 87:
Cardiovascular Diseaseoxidant, redu
Page 89 and 90:
Page 91 and 92:
Neurodegenerative Disease, Angiogen
Page 93:
Inflammation and Immunity
Page 96 and 97:
GE Healthcare Ltd.High content anal
Page 99 and 100:
Page 101 and 102:
Poster Session List
Page 103 and 104:
Poster Session List
Page 105 and 106:
Poster Session List
Page 107 and 108:
Poster Session List
Page 109 and 110:
Poster Session List
Page 111 and 112:
Poster Session List
Page 113 and 114:
Poster Session List
Page 115 and 116:
Poster Session List
Page 117 and 118:
Poster Session List
Page 119 and 120:
Poster Session List
Page 121 and 122:
Poster Session List
Page 123 and 124:
Poster Session List
Page 125 and 126:
Poster Session List
Page 127 and 128:
Poster Session List
Page 129 and 130:
Poster Session List
Page 131 and 132:
Poster Session List
Page 133 and 134:
Poster Session List
Page 135 and 136:
Poster Session List
Page 137 and 138:
Poster Session List
Page 139 and 140:
Poster Session List
Page 141 and 142:
Poster Session List
Page 143 and 144:
Poster Session List
Page 145 and 146:
Poster Session List
Page 147 and 148:
Poster Session List
Page 149 and 150:
Poster Session List
Page 151 and 152:
Poster Session List
Page 153 and 154:
Poster Session List
Page 155 and 156:
Poster Session List
Page 157 and 158:
Poster Session List
Page 159 and 160:
Poster Session List
Page 161 and 162:
Page 163 and 164:
Bioinformatics and systems biology
Page 165 and 166:
Page 167:
Page 170 and 171:
Cancer biologyB-17-01TrkC plays an
Page 172 and 173:
Cancer biologyB-17-13Syntenin posit
Page 174 and 175:
Cancer biologyB-17-25Role of CBR1 i
Page 176 and 177:
Cancer biologyB-17-38Secretory leuk
Page 178 and 179:
Cancer biologyB-17-50Thymoquinone (
Page 180 and 181:
Cancer biologyB-17-62Omega-3 polyun
Page 182 and 183:
Cancer biologyB-17-74Identification
Page 184 and 185:
Cancer biologyB-17-86Elevated fibro
Page 186 and 187:
Cancer biologyB-17-98Tissue inhibit
Page 188 and 189:
Cancer biologyB-17-111Sox10 control
Page 190 and 191:
Cancer biologyB-17-123Rsf-1 (HBXAP)
Page 192 and 193:
Cancer biologyB-17-135Syndecan-2 re
Page 194 and 195:
Cancer biologyB-17-147Involvement o
Page 196 and 197:
Cancer biologyB-17-159Overexpressio
Page 198 and 199:
Cancer biologyB-17-171IEX-1 is a cr
Page 200 and 201:
Cancer biologyB-17-183Clinical vali
Page 202 and 203:
Cell: differentiation, division and
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 219 and 220:
Page 221 and 222:
Chemical biology and drug discovery
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229:
Page 232 and 233:
Development and regenerationE-17-01
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Lipids and carbohydratesF-17-01Chan
Page 240 and 241:
MicrobiologyG-17-01Fatty acids incr
Page 242 and 243:
MicrobiologyG-17-13MARCH5, a mitoch
Page 244 and 245:
MicrobiologyG-17-25Discovery of che
Page 246 and 247:
NeuroscienceH-17-01N-Adamantyl-4-me
Page 248 and 249:
NeuroscienceH-17-12Inhibition of do
Page 250 and 251:
NeuroscienceH-17-24Neuroprotective
Page 252 and 253:
NeuroscienceH-17-37A novel BDNF-mod
Page 254 and 255:
NeuroscienceH-17-49Differential alt
Page 256 and 257:
NeuroscienceH-17-61Effect of volunt
Page 259 and 260:
Page 261:
Plant biology
Page 264 and 265:
Protein: structure and functionJ-17
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Biotechnology and bioengineeringK-1
Page 274 and 275:
Biotechnology and bioengineeringK-1
Page 277 and 278:
Page 279 and 280:
Cell: signal transduction
Page 281 and 282: Cell: signal transduction
Page 293 and 294: 2011KSBMBAnnual MeetingStepping int
Page 295: Cell: structure and physiology
Page 298 and 299: Genetics and genomics, epigeneticsN
Page 306 and 307: ImmunologyO-18-01Cilostazol protect
Page 308 and 309: ImmunologyO-18-14IL-18 is an import
Page 310 and 311: ImmunologyO-18-26Functions of novel
Page 312 and 313: ImmunologyO-18-39KIAA1542 gene prod
Page 317 and 318: Metabolism and metabolic diseases
Page 323: Metabolism and metabolic diseases
Page 326 and 327: Molecular medicine and imagingQ-18-
Page 331: Protein: modification and regulatio
Page 335: Proteomics
Page 338 and 339: RNA biologyT-18-01Genome-wide funct
Page 340 and 341: RNA biologyT-18-14Rapid molecular d
Page 342 and 343: OthersU-18-01Use of non-melanocytic
Page 344 and 345: OthersU-18-13Sulfuretin inhibits UV
Page 346 and 347: OthersU-18-25Suppressed expression
Page 348 and 349: OthersU-18-37Mismatch-repair relate
Page 350 and 351: OthersU-18-49AIP2, one of AROS inte
Page 352 and 353: Launching new technologies from the
Page 354 and 355: KSBMB’s NEXT MEETINGSSorak Confer
Page 356 and 357: 354Exhibition Booth Layout
Page 358 and 359: 기기전시 상호명별 부스번
Page 360 and 361: (주)기산바이오텍 부스번
Page 362 and 363: (주)대한과학 부스번호 : 16
Page 364 and 365: (주)메카시스 부스번호 : 61
Page 366 and 367: l(주)비바젠 부스번호 : 151,
Page 368 and 369: (주)아토코리아 부스번호 :
Page 370 and 371: (주)월드사이언스 부스번
Page 372 and 373: 천양테크 부스번호 : 38lCHUN
Page 374 and 375: 한국바이오래드 주식회사
Page 376 and 377: Product Indexactivity monitoring동
Page 378 and 379: iochemicals고마바이오텍㈜ 10
Page 380 and 381: 싸토리우스 코리아 바이오
Page 382 and 383:
cuvettes, elecroporation㈜고려
Page 384 and 385:
싸토리우스 코리아 바이오
Page 386 and 387:
enzyme immunoassay kits고마바이
Page 388 and 389:
㈜대명사이언스 159㈜디케
Page 390 and 391:
implantable instrumentation서린
Page 392 and 393:
micromanipulators㈜라이카 코
Page 394 and 395:
㈜휴컴시스템 137oxygen uptake
Page 396 and 397:
㈜대명사이언스 159㈜부경
Page 398 and 399:
㈜인실리코젠 133㈜케이오
Page 400 and 401:
한독바이오테크㈜ 64tissue c
Page 402 and 403:
Bio Job Fair 2011May 17 ~ 18, 2011H
Page 405 and 406:
Page 407 and 408:
U-18-06Cho, Young Jae ……B-17-18
Page 409 and 410:
Jang, Sei-Heon ………G-17-03Jang
Page 411 and 412:
P-18-31, S-18-08Kim, Jeewoong …
Page 413 and 414:
LLee, Areum …………P-18-29Lee,
Page 415 and 416:
Moon, Yun-Won ……C-17-81Morgan,
Page 417 and 418:
Shin, Jae-Sun ………J-17-31Shin,
show all

11:10-12:00, Rm 103

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?